Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 17Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 2Genitourinary 2Other solid neoplasm 1Gastrointestinal 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 1Prostate Adenocarcinoma 1

Interventions

Surveys and Questionnaires 52Blood Specimen Collection 47enzalutamide 29radium Ra 223 dichloride 22Biopsy 20darolutamide 19Radiotherapy 19Docetaxel 19apalutamide 18Sunitinib 18Magnetic Resonance Spectroscopy 18Sorafenib 17Abiraterone Acetate 17Watchful Waiting 16Interviews as Topic 15Gene Expression Profiling 15Amplified Fragment Length Polymorphism Analysis 15Observation 13Leuprolide 13Immunohistochemistry 13Androgen Antagonists 13acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 12Magnetic Resonance Imaging 12avelumab 11Specimen Handling 11abiraterone 9Polymerase Chain Reaction 9Flow Cytometry 9Radiosurgery 8Microarray Analysis 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Proton Therapy × Genitourinary × Clear all
NCT03159676 2026-02-25

Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer

Mayo Clinic

Completed
150 enrolled
Genitourinary

Prostatic Neoplasms

NCT01352429 2025-07-17

Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

Abramson Cancer Center at Penn Medicine

Active not recruiting
303 enrolled
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡